Kosei kubota

Dr. Kosei kubota

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
KKKosei kubota
Kosei kubota
RIRyohei Ito
Ryohei Ito
NNNorihiko Narita
Norihiko Narita
YTYusuke Tanaka
Yusuke Tanaka
KFKen Furudate
Ken Furudate
WKWataru Kobayashi
Wataru Kobayashi
Purpose: This study aimed to evaluate the utility of inflammation-based prognostic scores (IBPS) and systemic immune-inflammation index (SII) in the treatment of oral cancer patients.Methods: For the 183 patients enrolled in this study, IBPS and SII were calculated from peripheral blood samples obtained before and after treatment and at the time of relapse. We examined overall survival (OS) and disease-free survival (DFS) using previously reported cut-off values for IBPS. Cut-off values of neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) were analyzed as NLR 1.79, PLR 114.97, LMR 5, and PNI 52.44. The cut-off value for SII was set at 569. OS and DFS were analyzed by Kaplan–Meier methods using the cutoff of each IBPS and SII. Univariate analysis and multivariate analysis using Cox proportional hazards were performed for OS and DFS.Results: Kaplan–Meier methods showed the high-PNI group showed good prognosis including OS and DFS, while the high-SII group displayed poor DFS. Univariate analysis showed that pre-treatment high PNI and low SII were significantly associated with better prognosis. Multivariate analysis identified pre-treatment PNI as independently associated with OS. For DFS, univariate analysis using Cox proportional hazards modeling showed that pre-treatment high NLR and high SII were significantly associated with worse prognosis, while high PNI was significantly associated with better prognosis. Multivariate analysis identified pre-treatment PNI and SII as independently associated with DFS. Parameters of PNI and SII components were compared between pre-treatment, post-treatment and at relapse in the high- and low-PNI groups. PNI was predominantly decreased in both high- and low-PNI groups at post-treatment and at relapse compared to pre-treatment. This trend was also observed for albumin.Conclusions: Higher pre-treatment PNI was associated with better OS, while lower pre-treatment PNI and higher treatment SII were associated with poorer DFS in oral cancer patients. Our data indicated that PNI and SII might offer useful biomarkers for gauging prognosis and the efficacy of conventional therapies.

20 May 2015 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
KKKosei kubota
Kosei kubota
WKWataru Kobayashi
Wataru Kobayashi
HSHirotaka Sakaki
Hirotaka Sakaki
HNHiroshi Nakagawa
Hiroshi Nakagawa
TKTakao Kon
Takao Kon
HKHiroto Kimura
Hiroto Kimura

4 September 2025 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
KFKen Furudate
Ken Furudate
SKShuya Kasai
Shuya Kasai
TYTadashi Yoshizawa
Tadashi Yoshizawa
YSYuya Sasaki
Yuya Sasaki
KFKohei Fujikura
Kohei Fujikura
KTKoichi Takahashi
Koichi Takahashi
Lymph node metastasis (LNM) is a critical prognostic factor for patients with oral squamous cell carcinoma (OSCC). Previous research has implicated the partial epithelial-to-mesenchymal transition of tumor cells and myofibroblastic cancer-associated fibroblasts (myCAFs) in the LNM process. However, the underlying molecular mechanisms remain poorly understood. Here, we conducted a comprehensive molecular analysis integrating original and publicly available OSCC data from bulk genome and transcriptome, single-cell transcriptome, and spatial transcriptome analyses. We found that myCAFs were quantitatively and functionally activated in LNM-positive samples and spatially colocalized with OSCC cells within the invasive tumor front (ITF), providing a niche that may facilitate LNM. Immunohistochemical validation in 90 ITF samples confirmed significantly higher myCAF density in LNM-positive samples than in LNM-negative samples, and this density remained an independent predictor of LNM when adjusted for pathological grade and the pattern of invasion. In LNM-positive samples, myCAFs provided increased extracellular matrix (ECM) signals, upregulating stemness-related genes such as CD44 in OSCC cells. The functional importance of this myCAF-driven ECM-CD44 axis was further supported by our validation analysis of expanded, publicly available spatial transcriptome and experimental in vitro coculture data. We also extracted a spatially resolved, 23-gene signature from the metastatic ITF where OSCC and myCAFs colocalize. This signature predicted LNM status and poor overall survival in patients with OSCC. Our findings provide novel insight into the molecular myCAF/OSCC crosstalk that facilitates LNM and identify potential prognostic biomarkers and therapeutic targets for patients with OSCC.

1 March 2017 in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
Verified
Journal Article
Closed access
KKKosei kubota
Kosei kubota
RIRyohei Ito
Ryohei Ito
KFKen Furudate
Ken Furudate
TKTakao Kon
Takao Kon
HNHiroshi Nakagawa
Hiroshi Nakagawa
WKWataru Kobayashi
Wataru Kobayashi

15 April 2017 in Oral Science International
Verified
Journal Article
Open access
PDF file
AIAkinari Inui
Akinari Inui
RIRyohei Itou
Ryohei Itou
TOToshirou Oyama
Toshirou Oyama
YTYoshihiro Tamura
Yoshihiro Tamura
KKKosei kubota
Kosei kubota
WKWataru Kobayashi
Wataru Kobayashi
To compare the clinical characteristics of sialolithiasis between pediatric and adult patients. Subject characteristics, clinical manifestations, salivary calculi characteristics, and treatment modalities and outcomes from medical records were retrospectively compared between pediatric and adult patients with sialolithiasis visiting the Department of Oral and Maxillofacial Surgery, Hirosaki University Hospital, between 2005 and 2014. We included 5 pediatric (all boys) and 45 adult (20 men; 25 women) patients. Most patients had submandibular swelling. The calculi were located on the right in 100.0% of pediatric patients and 57.8% of adult patients. Moreover, 20.0% of pediatric patients and 35.6% of adult patients exhibited sialoliths in the glands. Calculi were <5 mm in size in 100.0% of pediatric patients and 33.3% of adult patients. Pediatric sialolithiasis treatment included intraoral retrieval under local anesthesia in 4 cases (80.0%) and spontaneous expulsion from the duct in 1 case (20.0%). Adult sialolithiasis treatment included gland resection under general anesthesia in 8 cases (17.8%), intraoral retrieval under general anesthesia in 6 cases (13.3%), intraoral retrieval under local anesthesia in 19 cases (42.2%), spontaneous expulsion in 6 cases (13.3%), and follow-up only in 6 cases (13.3%). A large number of relatively small and distal sialoliths in pediatric patients was removed using intraoral retrieval under local anesthesia. This difference in the choice of treatment between pediatric and adult sialolithiasis may be attributed to the size and palpability of the calculi.

28 December 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KKKosei kubota
Kosei kubota
KFKen Furudate
Ken Furudate
RIRyohei Ito
Ryohei Ito
NNNorihiko Narita
Norihiko Narita
YTYusuke Tanaka
Yusuke Tanaka
WKWataru Kobayashi
Wataru Kobayashi
The objective of this study was to evaluate the utility of inflammation-based prognostic scores (IBPS) in predicting ORN among patients undergoing superselective intra-arterial chemoradiotherapy (SSIACRT). This retrospective cohort study examined the medical records of 54 patients with advanced oral cancer (stage 3 or 4) treated with SSIACRT. The predictor variable was IBPS. The main outcome variable was onset of ORN. Covariates comprised sex, median age, tooth status, tumor size, and pretreatment tooth extraction with professional oral care (pretreatment tooth extraction). For each factor, cumulative incidence and univariate and multivariate analyses of ORN incidence were performed. The cumulative incidence of ORN in patients with pre-treatment lymphocyte-to-monocyte ratio (LMR < 4.95vs LMR ≥4.95, P = 0.01) and pretreatment tooth extraction (no vs. yes, P = 0.03) was significantly different. Univariate and multivariate analyses identified pre-treatment LMR cutoff values < 4.95 and pre-treatment tooth extraction as significantly associated with the development of ORN. Pretreatment tooth extraction reduced the incidence of ORN in low LMR group (P = 0.04). LMR is a useful biomarker to predict ORN in SSIACRT. Pretreatment tooth extraction was a useful treatment to prevent ORN. Pretreatment extraction with LMR may be important for the prevention of ORN in SSIACRT.